A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2009
12/10/2009	WO2009118759A3 Heterocyclic compounds as adenosine receptor antagonist
12/10/2009	WO2009103479A3 Cristallines, enantiomerically pure salt form of a betamimetic agent, and the use thereof as a medicament
12/10/2009	WO2007096782A3 Compositions for disorders associated wtth metachromatic cell activation
12/10/2009	US20090306216 Use of Beta-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain
12/10/2009	US20090306215 Deuterium-enriched arformoterol
12/10/2009	US20090306195 Fusion Proteins of Mycobacterium Tuberculosis
12/10/2009	US20090306141 Novel Compounds
12/10/2009	US20090306129 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
12/10/2009	US20090306105 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them
12/10/2009	US20090306102 2-pyridin-2-yl-quinazoline derivatives as potassium channel modulating agents for the treatment of respiratory diseases
12/10/2009	US20090306079 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
12/10/2009	US20090306074 Thiazolidinedione derivatives as p13 kinase inhibitors
12/10/2009	US20090306072 Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
12/10/2009	US20090306069 Azolidinone-vinyl fused-benzene derivatives
12/10/2009	US20090306025 Method and composition for skin inflammation and discoloration
12/10/2009	US20090306010 P1-(2'-deoxycytidine 5'-)p4-(uridine 5'-)tetraphosphate, tetra-(alkali metal) salt, for treating disorders
12/10/2009	US20090305991 33 Human Secreted Proteins
12/10/2009	US20090305985 Immunomodulatory Agents For Treatment of Inflammatory Diseases
12/10/2009	US20090305959 Use of Peptidic Vasopressin Receptor Agonists
12/10/2009	US20090305365 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
12/10/2009	US20090304802 Nasal delivery
12/10/2009	US20090304681 Methods for the treatment and prevention of infection using anti-selectin agents
12/10/2009	US20090304630 Treating severe and acute viral infections
12/10/2009	DE102008027331A1 Verwendung von Indol-3-carbonsäureestern zur Hemmung der mikrosomalen Prostaglandin E2 Synthase The use of indole-3-carboxylic acid esters to inhibit the microsomal prostaglandin E2 synthase
12/10/2009	CA2726885A1 Sirna of human osteopontin
12/10/2009	CA2726878A1 Novel treatments
12/10/2009	CA2726872A1 Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes
12/10/2009	CA2726644A1 Pharmaceutical combination
12/10/2009	CA2724882A1 Process for the synthesis of arformoterol
12/09/2009	EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009	EP2130830A1 Muscarinic receptor antagonists
12/09/2009	EP2129690A1 Engineered anti-tslp antibody
12/09/2009	EP2129668A1 Substituted phenoxy thiazolidinediones as estrogen related receptor-alpha modulators
12/09/2009	EP2129661A1 Quinoline derivatives as crth2 receptor ligands
12/09/2009	EP2129379A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors
12/09/2009	EP2129372A2 Anesthetic spray composition
12/09/2009	EP1392642B1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/09/2009	EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors
12/09/2009	EP1129110B1 Platelet-derived growth factor d, dna coding therefor, and uses thereof
12/09/2009	CN101600693A Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
12/09/2009	CN101600683A Therapeutic compounds
12/09/2009	CN101600475A Small compounds that correct protein misfolding and uses thereof
12/09/2009	CN101600421A Use of erss selective ligands for treating acute lung injuries
12/09/2009	CN101597337A Conjugate of hydroxyalkyl starch and an active agent
12/09/2009	CN101597285A 3-quinine ester quaternary ammonium salt and application in pharmacy
12/09/2009	CN101597262A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/09/2009	CN101597260A Novel muscarinic receptor antagonist and application thereof
12/09/2009	CN101596308A ITGB4BP and derivates thereof used for preventing and/or treating hypertrophic scar and fibrosis lesion
12/09/2009	CN101596291A New medicine for treating pharyngitis and preparation method thereof
12/09/2009	CN101596272A Medicine for treating chronic pharyngitis and preparation method thereof
12/09/2009	CN101596270A Medicine for treating chronic pharyngitis and preparation method thereof
12/09/2009	CN101596264A Traditional Chinese drug medicament for curing asthma
12/09/2009	CN101596257A Traditional Chinese drug medicament for curing middle-aged and aged bronchiectasis
12/09/2009	CN101596235A Traditional Chinese medicine for treating cold
12/09/2009	CN101596229A Pithecellobium clypearia extractive and quality control method of preparation thereof
12/09/2009	CN101596222A Refined ginkgo biloba extract, powder and preparation method thereof
12/09/2009	CN101596178A Medicine composition for treating cold
12/09/2009	CN101596160A Alpha-asarone mixed micelle injectio and preparation method thereof
12/09/2009	CN101596158A Compound slow release preparation of acetyl aminophenol, pseudoephedrine and dextromethorphan
12/09/2009	CN101596157A Compound slow release preparation of pseudoephedrine, chlorphenamine and dextromethorphan
12/09/2009	CN101596156A Compound sustained-release preparation for paracetamol and pseudoephedrine
12/09/2009	CN100567495C Methods for large scale production of recombinant DNA-derived tPA or K2S molecules
12/09/2009	CN100567489C Antiallergic agent and pharmaceutical use thereof
12/09/2009	CN100567483C FAD4, FAD5, FAD5-2 and FAD6 fatty acid desaturase enzyme family members and uses thereof
12/09/2009	CN100567322C Polypeptide for inhibiting growth differentiation factor activity and cell expressing the same
12/09/2009	CN100567303C Coumarether compound and use of its composition
12/09/2009	CN100567266C Cannabinoid receptor ligands
12/09/2009	CN100566749C Particle medicinal granules for treating pharyngitis and method of producing the same
12/09/2009	CN100566735C Medicinal composition for treating acute and chronic pneumonia, its preparation method and use
12/09/2009	CN100566726C Medicament for treating chronic rhinitis sinusitis
12/08/2009	US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders
12/08/2009	US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009	US7629363 Diaryl substituted pyridinones
12/08/2009	US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/08/2009	US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009	US7629335 comprising a drug compound 6 alpha ,9 alpha -Difluoro-17 alpha -[(2-furanylcarbony)oxy]-11 beta -hydroxy-16 alpha -methyl-3-oxo-androsta-1,4-diene-17 beta -carbothioic acid S-fluoromethyl ester; dry powder inhaler; with predictable pharmacokinetic and pharmacodynamic behaviour
12/08/2009	US7629327 Chlamydia 60 Kda CRMP antigens and vaccine uses
12/08/2009	US7629324 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
12/08/2009	US7629146 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent; inhibits the migration of cultured cells as well as inhibiting angiogenesis, tumor growth, or any other processes that involve the migration of cells in vivo
12/08/2009	US7628988 Induce cell differentiation; process control
12/08/2009	US7628984 Micronutrient formulations for pulmonary and heart health
12/08/2009	US7628978 Stabilized preparations for use in metered dose inhalers
12/08/2009	CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009	CA2422342C Novel amide derivatives and medicinal use thereof
12/08/2009	CA2419301C Quinazoline derivatives
12/08/2009	CA2404725C Extrusion die
12/08/2009	CA2375986C Substituted pyrazole compounds
12/08/2009	CA2359242C Growth differentiation factor inhibitors and uses therefor
12/08/2009	CA2355075C Heteroaryl-cyclic acetals
12/08/2009	CA2218116C Pulmonary delivery of aerosolized medicaments
12/03/2009	WO2009146104A1 Formulations, devices and methods for treating and preventing mucositis
12/03/2009	WO2009145989A2 Aminoalkylphenyl antagonists of prostaglandin d2 receptors
12/03/2009	WO2009145238A1 Immunomodulatory agent and use thereof
12/03/2009	WO2009144037A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
12/03/2009	WO2009143865A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
12/03/2009	WO2009143584A1 Treatment of pulmonary edema
12/03/2009	WO2009043479A3 Use of eaa-mart1 (26-35) for the treatment of human cytomegalovirus infections
12/03/2009	WO2009043478A3 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections
12/03/2009	WO2009039310A3 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment
12/03/2009	WO2009024677A3 Use of hyaluronic acid for preparing compositions for improving the function of skin, eye and mucous membrane protection

1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 878